202 related articles for article (PubMed ID: 35027621)
1. Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes.
Cava C; Armaos A; Lang B; Tartaglia GG; Castiglioni I
Sci Rep; 2022 Jan; 12(1):693. PubMed ID: 35027621
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs differential expression in breast cancer subtypes: What do we know?
Mathias C; Zambalde EP; Rask P; Gradia DF; de Oliveira JC
Clin Genet; 2019 May; 95(5):558-568. PubMed ID: 30614523
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
4. The abundance of the long intergenic non-coding RNA 01087 differentiates between luminal and triple-negative breast cancers and predicts patient outcome.
De Palma FDE; Del Monaco V; Pol JG; Kremer M; D'Argenio V; Stoll G; Montanaro D; Uszczyńska-Ratajczak B; Klein CC; Vlasova A; Botti G; D'Aiuto M; Baldi A; Guigó R; Kroemer G; Maiuri MC; Salvatore F
Pharmacol Res; 2020 Nov; 161():105249. PubMed ID: 33068730
[TBL] [Abstract][Full Text] [Related]
5. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
6. The role of long noncoding RNAs in patients with Luminal A invasive breast ductal carcinoma.
Eshghifar N; Rouhollah F; Barikrow N; Pouresmaeili F; Taheri M
Pathol Res Pract; 2021 Nov; 227():153645. PubMed ID: 34678601
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.
Vu TN; Pramana S; Calza S; Suo C; Lee D; Pawitan Y
Oncotarget; 2016 Oct; 7(42):68851-68863. PubMed ID: 27634900
[TBL] [Abstract][Full Text] [Related]
8. Systematical analysis of lncRNA-mRNA competing endogenous RNA network in breast cancer subtypes.
Zhou S; Wang L; Yang Q; Liu H; Meng Q; Jiang L; Wang S; Jiang W
Breast Cancer Res Treat; 2018 Jun; 169(2):267-275. PubMed ID: 29388017
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA00544 serves as a potential novel predictive and prognostic marker for HR+ HER2- subtype breast cancer.
Liu L; Chi Y; Chen J; Xue J; Deng L; Huang N; Shao J; Wu J
Sci Rep; 2017 Sep; 7(1):12382. PubMed ID: 28959047
[TBL] [Abstract][Full Text] [Related]
10. Abnormal Long Non-Coding RNAs Expression Patterns Have the Potential Ability for Predicting Survival and Treatment Response in Breast Cancer.
Pavanelli AC; Mangone FR; Barros LRC; Machado-Rugolo J; Capelozzi VL; Nagai MA
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34209776
[TBL] [Abstract][Full Text] [Related]
11. A Competing Endogenous RNA Network Reveals Novel lncRNA, miRNA and mRNA Biomarkers With Diagnostic and Prognostic Value for Early Breast Cancer.
Luo ZB; Lai GE; Jiang T; Cao CL; Peng T; Liu FE
Technol Cancer Res Treat; 2020; 19():1533033820983293. PubMed ID: 33371806
[TBL] [Abstract][Full Text] [Related]
12. Detection of subtype-specific breast cancer surface protein biomarkers via a novel transcriptomics approach.
Mercatelli D; Formaggio F; Caprini M; Holding A; Giorgi FM
Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34750607
[TBL] [Abstract][Full Text] [Related]
13. Multidimensional crosstalk between RNA-binding proteins and noncoding RNAs in cancer biology.
Li L; Miao H; Chang Y; Yao H; Zhao Y; Wu F; Song X
Semin Cancer Biol; 2021 Oct; 75():84-96. PubMed ID: 33722631
[TBL] [Abstract][Full Text] [Related]
14. The potential roles of lncRNAs DUXAP8, LINC00963, and FOXD2-AS1 in luminal breast cancer based on expression analysis and bioinformatic approaches.
Arabpour M; Layeghi SM; Bazzaz JT; Naghizadeh MM; Majidzadeh-A K; Shakoori A
Hum Cell; 2021 Jul; 34(4):1227-1243. PubMed ID: 34043149
[TBL] [Abstract][Full Text] [Related]
15. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms.
Sørlie T; Wang Y; Xiao C; Johnsen H; Naume B; Samaha RR; Børresen-Dale AL
BMC Genomics; 2006 May; 7():127. PubMed ID: 16729877
[TBL] [Abstract][Full Text] [Related]
16. Quantitative proteomics revealed novel proteins associated with molecular subtypes of breast cancer.
Suman S; Basak T; Gupta P; Mishra S; Kumar V; Sengupta S; Shukla Y
J Proteomics; 2016 Oct; 148():183-93. PubMed ID: 27498393
[TBL] [Abstract][Full Text] [Related]
17. Metabolism-related long non-coding RNAs (lncRNAs) as potential biomarkers for predicting risk of recurrence in breast cancer patients.
Ma JY; Liu SH; Chen J; Liu Q
Bioengineered; 2021 Dec; 12(1):3726-3736. PubMed ID: 34254565
[TBL] [Abstract][Full Text] [Related]
18. A Novel Prognostic Signature of mRNA-lncRNA in Breast Cancer.
Liu Q; Wang Z; Kong X; Wang X; Qi Y; Gao R; Fang Y; Wang J
DNA Cell Biol; 2020 Apr; 39(4):671-682. PubMed ID: 32040341
[TBL] [Abstract][Full Text] [Related]
19. Decoding the usefulness of non-coding RNAs as breast cancer markers.
Amorim M; Salta S; Henrique R; Jerónimo C
J Transl Med; 2016 Sep; 14():265. PubMed ID: 27629831
[TBL] [Abstract][Full Text] [Related]
20. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]